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Background: Anxiety and stress-related disorders are among the most common psychiatric disorders. The
hippocampus is a crucial brain area involved in the neural circuits of the pathophysiology of anxiety and stress-related
disorders, and GABA is one of most important neurotransmitters related to these disorders. An anxiogenic drug and a
pharmacological stressor, FG7142 (N-methyl-ß-carboline-3-carboxamide), produces anxiety in humans and
experimental animals, acting at the benzodiazepine sites of the GABAA receptors as a partial inverse agonist. This drug
as well as immobilization stress produced an increased mRNA in a number of genes, e.g., Btg2 and Adamsts1, in the
cortex of rodents. The present study was carried out to clarify the effect of the anxiogenic drug on the gene
expressions in the hippocampus and to obtain a new insight into the GABAergic system involved in the
pathophysiology of the disorders.
Method: We examined the effects of FG7142 on the gene expression of Btg2 and Adamts1 in the hippocampus of
mice using a quantitative RT-PCR method as well as an in situ hybridization method.
Results: The intraperitoneal administration of FG7142 at a dose of 20 mg/kg, but not 10 mg/kg, induced a statistically
significant increase in the hippocampal mRNA of both genes in adult mice (postnatal days 56), being blocked by
co-administrations of flumazenil (twice of 10 mg/kg, i.p.), an antagonist at the benzodiazepine binding site, while
FG7142 failed to produce any change in the gene expressions in infant mice (postnatal days 8). In addition, the in situ
hybridization experiment demonstrated an upregulation of the gene expressions restricted to the dentate gyrus of the
hippocampus in adult mice.
Conclusions: The present study suggests a functional coupling between the GABAergic system and the transcriptional
regulation of the two genes (Btg2 and Adamsts1) in the hippocampus of adult mice, which may play a role in the
brain function related to anxiety and stress such as memory of fear.
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DevelopmentBackground
FG7142 (N-methyl-ß-carboline-3-carboxamide), an anxio-
genic drug and/or a pharmacological stressor, produces
anxiety in humans [1], rhesus monkeys[2] and rodents [3,4]
along some physiological and neurochemical changes
related to anxiety and stress [5]. Both FG7142 and stress,
such as foot-shock and restraint stress, similarly produce an* Correspondence: 0724.psyc@tmd.ac.jp
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distribution, and reproduction in any mediumincreased release of dopamine [6,7], noradrenaline [8,9],
and glutamate in the cerebral cortex of rodents [10]. In
addition, FG7142 produced an increased Fos-like immu-
noreactivity in the cortex of rats along with some brain
areas associated with neuronal circuits mediating anxiety
and stress-responses [11-14]. FG 7142 acts at the benzodi-
azepine sites of the GABAA receptors as a partial inverse
agonist and allosterically inhibits the ability of GABA to
bind to and activate the receptors, which can be blocked by
a benzodiazepine antagonist, e.g., flumazenil (Ro 15–1788)
[15]. We have previously reported an increase in theed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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the cortex of mice as a consequence of the modulation of
the GABAA receptors by the systemic administration of
FG7142 [16]. In addition, exposure to a novel circumstance
induced an acute increase in the gene expression of Btg2 in
the hippocampus [17].
The hippocampus is known to be a crucial structure
for the formation of certain types of memory, such as
episodic memory and spatial memory [18]. Several lines
of evidence have led to the view that the hippocampus
also plays an important role in the memory of fear, an
emotional state induced by a frightening event or stress
[19]. In addition, new neurons are continuously added
to the hippocampus throughout adult life in various spe-
cies including humans [20]. The adult hippocampal neu-
rons originate from a radial glia-like precursor cell
(Type 1) in the subgranular zone of the dentate gyrus
through a number of intermediate cell types (types 2
and 3). After an early postmitotic maturation stage, asso-
ciated with dendrite and axon elongation and selective
survival, the newborn granule cells fully integrate into
the DG circuitry as well as the functions of the hippo-
campus [21].
Btg2 is an antiproliferative gene involved in the control
of the cell cycle progression, specifically in the G1 to S
transition [22,23]. Btg2 is specifically expressed in neuro-
genic precursor cells but not in postmitotic neurons
during embryonic neurogenesis [24,25]. During adult
hippocampal neurogenesis in newly generated cells, Btg2
was absent from the radial glia-like putative stem cells
(type-1), first appeared in the transient amplifying pro-
genitor cells (type-2 and −3 cells), was expressed again
in maturing neurons, and finally decreased in mature
granule cells. It is likely that the Btg2 expression in ma-
turing granule cells might be linked to integration into the
already existing neuronal networks and is subject to the
inputs of various neurotransmitter systems during the
maturation. Moreover, the involvement of Btg2 during
fear conditioning was suggested by a behavioral experi-
ment using the knock-out mice [26] and a genome-wide
association study using a trait loci mapping method [27].
Adamts1 is the first member of ADAMTS (a disintegrin
and metalloprotease with thrombospondin motifs) [28]
and has been shown to display anti-angiogenic properties
[29] and a role in the turnover of the extracellular matrix
in the central nervous system [30]. It has been reported
that the gene expression of Adamts1 was increased by an
insult of ischemia in the hippocampus [31] and cerebral
cortex [32,33] of rodents.
In the present study, we examined the effects of FG7142
on the gene expression of Btg2 and Adamsts1 in the hippo-
campus using a RT-PCR method and carried out an in situ
hybridization experiment in order to obtain anatomically
detailed information on the drug-effect in the brain area.Methods
Animals and chemicals
The present animal experiments were performed in
strict accordance with the guidelines of the Tokyo Med-
ical and Dental University and were approved by the
Animal Investigation Committee. Male C57BL mice
(Japan Clea Laboratories, Japan) at postnatal days (PND)
56 (body weights; 20–23 g) or 8 (body weights; 3.5-
5.5 g) were used. The mice were kept at 24.0 ± 0.5°C in a
humidity-controlled room under a 12-h light–dark cycle
(lights on at 8:00 AM) with free access to food and
water. The animal experiments were conducted during
the light cycle.
FG7142 (N-methyl-ß-carboline-3-carboxamide)(TOCRIS,
Bristol, UK) and flumazenil (ethyl-8-fluoro-5,6-dihydro-5-
methyl-6-oxo-4 H-imidazo[1,5-a][1,4] benzodiazepine-3-
carboxylate) [a gift from the Astellas Pharmaceutical Com-
pany (Tokyo, Japan)] were dissolved in saline/40% 2-hydro-
xypropyl-ß-cyclodextrin (Nacalai Tesque, Kyoto, Japan). FG
7142 was injected intraperitoneally in a volume of 10 ml/kg
(PND 8) or in a volume of 5 ml/kg (PND 56). The control
animals received only the vehicle. Flumazenil (10 mg/
5ml/kg) was subcutaneously injected in the mice twice at
15 min before and 20 min after the injection of FG7142,
taking into account the relatively short action of the drug.
Consequently, the experiment consisted of four groups of
animals, namely the vehicle + vehicle, vehicle + FG7142, flu-
mazenil + vehicle and flumazenil + FG7142. No animals
exhibited seizures in the behavioral monitoring throughout
the experiments.
Extract of total RNA
The mice were killed by cervical dislocation one hour
later after the administration of FG7142. Both sides of
the hippocampus were rapidly removed in the cold, fro-
zen in liquid nitrogen, and stored at −80°C prior to use.
Each frozen cortical tissue section was homogenized
using a Polytron Homogenizer (Kinematica AG, Littau/
Luzern, Switzerland) at 24,000 rpm for 10 sec, and its
total RNA was extracted using the Quiagen Rneasy Midi
System (Quiagen, Valencia, CA, USA).
Quantitative RT-PCR
The RNA sample was treated with RNase-free DNase I
(Invitrogen, Carlsbad, CA, USA) to remove any contam-
inating genomic DNA. The single-stranded cDNA was
then synthesized from 1 μg of the DNase I-treated neo-
cortical RNA using a SuperScript Preamplification sys-
tem (Invitrogen, Carlsbad, CA, USA). The remaining
RNAs were digested using Ribonuclease H (Invitrogen,
Carlsbad, CA, USA), and the resulting cDNA suspended
in 10 volumes of TE buffer (10 mM Tris–HCl, pH 8.0,
and 1 mM EDTA) was used for the quantitative RT-PCR
analysis described below.
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was amplified using 2μL of LightCycler FastStart DNA
Master SYBER Green I (Roche Diagnostics, Mannheim,
Germany) [34] and a pair of primers (Table 1) at the final
concentration of 0.5 μM each and MgCl2 at the final con-
centration of 3 mM. PCR was performed in a total volume
of 20 μL for 10 min at 95°C and 40 cycles of 15 s at 95°C,
5 s at 65°C and 10s at 72°C. The melting curve analysis
was done by continuous acquisition from 65°C to 95°C
with a temperature transition rate of 0.1°C/sec. In each
assay, standard curves were generated from four increas-
ing amounts of the pooled cDNA templates of equal
volumes of the individual samples. The results were auto-
matically calculated using the respective standard curves
by the LightCycler analysis software version 3.5. Amplifi-
cation of the single product in the RT-PCR was confirmed
by monitoring the melting curve and by agarose gel elec-
trophoresis. Expression of the glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) was determined as the internal
standard for each sample, because the Gapdh gene has
been reported to be a housekeeping gene that is constantly
expressed in neural tissues [35]. The ratios of the results
of the mRNAs of each gene to those of the Gapdh
mRNAs were used for the statistical comparison as the
normalized values of the mRNA of each gene.
In situ hybridization
In situ hybridization was performed as previously des-
cribed [36,37]. Anaesthetized male mice at post-natal
day 56 were fixed by perfusion with tissue fixative
(GenoStaff, Tokyo, Japan) and the whole brain was em-
bedded in paraffin. A 410-bp DNA fragment correspond-
ing to the nucleotide position 893–1302 of the mouse
Btg2 cDNA (GenBank accession number NM_007570) or
a 465-bp DNA fragment corresponding to the nucleotide
position 75–539 of the mouse Adamts1 cDNA (GenBank
accession number NM_009621) was subcloned into the
pBluescript II KS(+) vector (Stratagene, La Jolla, CA,
USA). Digoxigenin (DIG)-labeled single-stranded ribop-
robes (antisense and sense as the control) were prepared
by in vitro transcription using the T7 or T3 RNA polymer-
ase (DIG northern starter kit, Roche, Nonnenberg,Table 1 Primer sequences for the semi-quantitative RT-PCR





B-cell translocation gene 2
Adamts 1 NM_009621. 550-896
A disintegrin-like and metalloprotease
with thrombospondin type 1Germany). Hybridization was performed with the DIG-
labeled RNA probes at 60°C for 18 h. The bound label was
detected using NBT-BCIP, an alkaline phosphatase color
substrate, and tissue slides were counterstained with Ker-
nechtrot stain solution (Muto Pure Chemicals, Tokyo,
Japan).
Statistical analysis
Data are expressed as a percentage of the control and
are mean ± SEM. Differences between two groups were
tested with the two-tailed Student’s t-test. Differences
between more than two groups were tested with one-
ANOVA followed by the post hoc Dunnett’s test or two-
way ANOVA followed by the Sheffe’s test.
Results
The systemic injection of FG 7142 at a dose of 20 mg/kg
induced a statistically significant increase in the mRNA
of Btg2 [F (16,2) = 5.048, p < 0.05] as well as Adamts1
[F (2, 18) = 4.35, p < 0.05] in the hippocampus of the
mice (Figure 1A). In the infant mice, however, there were
no changes in the mRNA of either gene in the hippocam-
pus after treatment with FG 7142 (20 mg/kg, i.p.)
(Figure 1B). We examined the effects of co-administrations
of flumazenil on the FG 7142-induced increases in the
mRNAs of the genes (Figure 2). Two-way ANOVA revealed
a significant effect of treatment with FG 7142 [Btg2: F
(1,24) = 8.005, p <0.01; Adamts1: F (1,24) =7.925, p< 0.01]
and a significant effect of treatment with flumazenil [Btg2:
F (1,24) = 16.238, p <0.001; Adamts1: F (1,24) =12.897,
p <0.01] on the mRNA of the both genes. The analysis
revealed a significant effect of the interaction of FG 7142 x
flumazenil on the mRNA of Btg2 [F (1,24) = 8.169, p< 0.01]
but not on the Adamts1 [F (1,25) =3.619]. Treatment with
FG 7142 failed to produce a statistically significant change
in the mRNA expression levels of both genes in mice re-
ceiving the co-administrations of the benzodiazepine antag-
onist, while the administration of FG 7142 induced a
statistically significant increase in the mRNA levels of the
genes in mice injected with the vehicle of the antagonist. In
addition, there was no difference between the hippocampal




Figure 1 Results of RT-PCR after treatment with FG 7142 in the
hippocampus of (A) adult and (B) neonatal mice. FG 7142 (10 or
20 mg/kg) or the vehicle was intraperitoneally injected into the
adult (postnatal days 56) and neonatal (postnatal days 8) mice. The
mice were sacrificed at one hour after the administration. (A) The
data of adult mice are presented as a percentage of the mean value
of the vehicle-treated mice and are mean± SEM obtained from 6 or
7 animals. The statistical analysis was carried out by one-way ANOVA
followed by the post hoc Dunnett’s test. * p < 0.05 compared to the
vehicle-treated controls. (B) The data of neonatal mice are presented
as a percentage of the mean value of the vehicle-treated mice and
are mean± SEM obtained from 9 or 10 animals.
Figure 2 Results of RT-PCR in the hippocampus of adult mice
after treatment with flumazenil and FG 7142. FG 7142 (20 mg/kg)
or the vehicle was intraperitoneally injected into the adult mice
(postnatal days 56) one hour before their sacrifice. Flumazenil (10 mg/
kg) or the vehicle was subcutaneously injected into the mice twice, at
15 minutes before and 20 minutes after the administration of FG 7142
or the vehicle. Thus, the experiment consisted of four groups of
animals, namely the vehicle + vehicle (V+ V), vehicle + FG 7142 (V+ FG),
flumazenil + vehicle (Flu+ V) and flumazenil + FG 7142 (Flu + FG). The
data are expressed as a percentage of the mean value of the vehicle
and vehicle-treated mice (V+V) and are mean± SEM obtained from 6
or 7 animals. The statistical analysis was carried out by two-way
ANOVA followed by the post hoc Sheffe’s test. a; p < 0.001 vs
Vehicle + FG 7142, b; p < 0.01 vs Vehicle+ FG 7142, c; p < 0.05 vs
Vehicle + FG 7142.
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treated with flumazenil and the vehicle of FG7142.
A prominent increase in the Btg2 mRNA signals with
the DIG-labeled anti-sense RNA probe was observed in
the molecular layer of the dentate gyrus of mice receiving
the injection of 20 mg/kg of FG 7142, while there were
sparse signals of the mRNA of Btg2 in the brain area of
mice after the administration of the vehicle (Figure 3). In
addition, treatment with FG 7142 induced an increase in
the number of cells showing the Adamts1 signals detected
by the anti-sense RNA probe in the molecular layer of the
dentate gyrus, compared to those of mice receiving the ve-
hicle (Figure 4).
Discussion
FG7142 has been shown to induce anxiety-related be-
havioral and physiological responses in a variety ofexperimental paradigms across numerous mammalian
species including humans [1-5] and to activate an anxiety-
related neural network interacting [13,14] with other sys-
tems of neurotransmitters such as monoamines [6-9] and
excitatory amino acid [10]. The anxiogenic effect of
FG7142 on rodents assessed by the elevated plus-maze
was demonstrated at doses between 10 and 100 mg/kg
[3-5,15]. The RT-PCR experiments demonstrated that the
mRNAs of Btg2 and Adamsts1 in the hippocampus of
adult mice were increased by the systemic administration
of FG7142 at a dose of 20 mg/kg, but not of 10 mg/kg. Be-
cause the drug failed to induce a significant increase in
the hippocampal mRNAs in adult mice receiving the co-
administrations of flumazenil, an antagonist at the benzo-
diazepine binding sites within the GABAA receptors, it is
postulated that the effects of FG7142 on the gene expres-
sion can be mediated via action of the drug as a partial in-
verse agonist at the benzodiazepine site.
The experiments of in situ hybridization clearly
demonstrated that the FG7142-induced increases in the
gene expression of the genes were confined to the den-
tate gyrus of the hippocampus, whereas it has been
established that the benzodiazepine sites show a high
density during the hippocampal formation including the
dentate gyrus as well as Ammon’s horn [38]. Atack et al.
reported that FG7142 had a relatively higher affinity for
the α1 subunit than the other α subunits at the
Figure 3 In situ hybridization histochemistry of Btg2 in the hippocampus of adult mice after treatment with FG 7142. The coronal
section at the hippocampus level of the adult (postnatal days 56) mouse brain was hybridized with the anti-sense and sense strands of Btg2. The
RNA signals are detected by the DIG system as shown in the purple color, and the cell nuclei are counterstained with Kernechtrot solution as
shown in pink. a and e; vehicle-treated mice hybridized with the anti-sense probe, b and f; vehicle-treated mice hybridized with the sense probe,
c and g; FG 7142-treated mice hybridized with the anti-sense probe, d and h; FG 7142-treated mice hybridized with the sense probe.
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abundant localization of the α1 subunit in the dentate
gyrus was similarly demonstrated by immunocytochem-
ical studies [39,40]. Thus, it is likely that a coupling be-
tween the GABAA receptors and the transcriptionalFigure 4 In situ hybridization histochemistry of Adamts1 in the hippo
section at the hippocampus level of the adult (postnatal days 56) mouse b
The RNA signals are detected by the DIG system as shown in the purple co
shown in pink. a, e and g; vehicle-treated mice hybridized with the anti-se
probe, c, i and k; FG 7142-treated mice hybridized with the anti-sense probregulations of Btg2 and Adamsts1 is mainly associated
with the subunit in the area.
The dentate gyrus is a key anatomical region of the ex-
citatory trisynaptic pathway in the hippocampus. The
axons of the layer II neurons in the entorhinal cortexcampus of adult mice after treatment with FG 7142. The coronal
rain was hybridized with the anti-sense and sense strands of Adamts1.
lor, and the cell nuclei are counterstained with Kernechtrot solution as
nse probe, b, f and h; vehicle-treated mice hybridized with the sense
e, d, j and l; FG 7142-treated mice hybridized with the sense probe.
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pathway. The dentate gyrus sends projections into the
pyramidal cells in CA3 through mossy fibers. The CA3
pyramidal neurons relay information to CA1 pyramidal
neurons through the Schaffer collateral. The CA1 pyr-
amidal neurons send back-projections into the deep-
layer neurons of the entorhinal cortex [21]. In addition,
adult neurogenesis, originating from neural progenitor
cells, is observed in the subgranular zone of the dentate
gyrus. Neurons born in the subgranular zone differenti-
ate and integrate into the local neural network as gran-
ule cells of the dentate gyrus by regulations of the
GABAergic and glutamatergic synaptic inputs [21].
Btg2 is a transcriptional co-factor endowed with anti-
proliferative and prodifferentiative properties. During
embryonic neurogenesis, the expression has been asso-
ciated with the switch from proliferation to neurogenesis
and lengthening of the cell cycle [41,42]. The expression
of Btg2 has been detected in the dentate gyrus of the
adult hippocampus, in type-2 progenitor cells and in dif-
ferentiated neurons [43]. We have recently reported that
exposure to a novel circumstance, a mild psychological
stressor, induced an acute and short-lasting increase in
the mRNA of Btg2 in the hippocampus of mice [17].
Btg2-null mice showed impairment in contextual fear
conditioning, without any deficit in spatial memory [26].
In addition, a genome-wide association study of fear
conditioning using a quantitative trait loci mapping
method and bioinformatic analyses identified a number
of candidate genes including Btg2 as well as subunits of
GABAA receptors, e.g., Gabra2 (GABAA receptor, sub-
unit α-2) and Gabra1b (GABAA receptor, subunit β-1)
[27]. Thus, the present study suggests that there may be
a functional coupling between the GABAA receptors and
expression of the Btg2 gene in the discrete brain area
and that the anxiogenic drug-induced gene expression in
the matured neurons may play a role in the early stage
of the molecular system responsive to anxiety and/or
stress.
The present study also demonstrated the transcrip-
tional activation of the Adamts1 gene by the partial in-
verse agonist of the benzodiazepine receptors in the
hippocampus of adult mice, while the previous study
showed no responses of the gene to the novelty stress in
the hippocampus [17]. The effect of the novelty stress
on the neural transmission of the GABAA receptors
may be different from that of the benzodiazepine
receptors-related drug in magnitude and/or manner, as
the brain responsive system to stress involves various
neurotransmitters [5] and consists of neuronal circuits
[11-14].
There were no changes in the hippocampal gene expres-
sions of infant mice after treatment with FG7142 in the
present study. We have previously shown age-dependentinductions of a number of genes by schizophrenomimetic
drugs. The acute treatment with phencyclidine or meth-
amphetamine significantly increased the neocortical ex-
pression of the genes (e.g., mrt1 [44], Cyr61 [45] and
leiomodin2 [46]) at postnatal day 56, but not at postnatal
day 8, suggesting that there was a relation with the devel-
opmentally regulated drug-induced abnormal behaviors.
Physiological functions of the GABAA receptors in the
hippocampal neurons during the first postnatal week are
significantly different from those of the adult brain, pro-
viding an excitatory rather than inhibitory drive due to a
different Cl- gradient [47]. Thus, further studies are
required to identify the developmental age showing the
crucial alteration in the induction of the Btg2 and
Adamsts1 genes as well as behavioral alterations asso-
ciated with anxiety after treatment with the anxiogenic
drug.
Conclusions
Because several lines of evidence indicate the involve-
ment of GABAA receptors in the function of the hippo-
campus associated with not only anxiety and fear but
also memory and learning [18,19], the present study sug-
gests that the transcriptional activation of Btg2 and
Adamts1 followed by the anxiogenic drug-induced re-
duction in the transmission of the GABAA receptors in
the adult hippocampus may be involved in changes of
the neural functions in the emotional states and memory
of the experience. Consequently, further investigations
are necessary to clarify the cascade of the molecular re-
sponse including translations of the mRNAs as well as
the consequence of physiological function in the hippo-
campus after the enhanced gene expressions.
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